The Interim Results of a Multicenter study of Safety and Efficacy of Vemurafenib and Cytarbine plus Cladribine Therapy in high-risk Pediatric Langerhans cell Histiocytosis with Braf V600E Mutation

被引：0

作者：

Evseev, Dmitry ^{[1
]}

Osipova, Daria ^{[1
]}

Kalinina, Irina ^{[1
]}

Raykina, Elena ^{[1
]}

Popov, Alexander ^{[1
]}

Kotskaya, Natalia ^{[1
]}

Chernyak, Ekaterina ^{[1
]}

Burtsev, Evgeny ^{[2
]}

Bronin, Gleb ^{[2
]}

Tayshikhina, Irina ^{[2
]}

Purbueva, Bazarma ^{[3
]}

Fink, Olesya ^{[3
]}

Pristanskova, Ekaterina ^{[3
]}

Novitchkova, Galina ^{[1
]}

Maschan, Alexey ^{[1
]}

Maschan, Michael ^{[1
]}

机构：

[1] Dmitry Rogachev Natl Res Ctr, Moscow, Russia

[2] Morozovskaya Children City Clin Hosp, Moscow, Russia

[3] Russian Childrens Clin Hosp, Moscow, Russia

来源：

PEDIATRIC BLOOD & CANCER | 2022年 / 69卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S6 / S6

页数：1

共 50 条

[1] Clinicopathological Analysis of BRAF V600E Mutation in Pediatric Langerhans Cell Histiocytosis
Wang, R.
Sun, Y.
Guan, W.
Yu, W.
Qiao, M.
Wang, L.
PEDIATRIC BLOOD & CANCER, 2019, 66 : S364 - S365
[2] BRAF V600E Mutation in Pediatric Langerhans Cell Histiocytosis and its Clinical Significance
Wang, Dong
Zhang, Rui
Lian, Hong-yun
Ma, Hong-hao
Gao, Chao
Wang, Tian-you
Zhang, Li
PEDIATRIC BLOOD & CANCER, 2016, 63 : S35 - S35
[3] Langerhans cell histiocytosis associated with chronic myelomonocytic leukaemia both harbouring the same BRAF V600E mutation: efficacy of vemurafenib
Konstantinou, M. P.
Lucas, P.
Uthurriague, C.
Severino-Freire, M.
Spenatto, N.
Gaudin, C.
Lamant, L.
Tournier, E.
Bulai-Livideanu, C.
Meyer, N.
Paul, C.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (02) : E120 - E121
[4] The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis
Ballester, Leomar Y.
Cantu, Miguel D.
Lim, Karen P. H.
Sarabia, Stephen F.
Ferguson, Lizmery Suarez
Webb, C. Renee
Allen, Carl E.
McClain, Kenneth L.
Mohila, Carrie A.
Punia, Jyotinder N.
Roy, Angshumoy
Lopez-Terrada, Dolores H.
Hicks, M. John
Fisher, Kevin E.
HEMATOLOGICAL ONCOLOGY, 2018, 36 (01) : 307 - 315
[5] Major response to vemurafenib in patient with severe cutaneous Langerhans cell histiocytosis harboring BRAF V600E mutation
Charles, Julie
Beani, Jean-Claude
Fiandrino, Giacomo
Busser, Benoit
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 71 (03) : E97 - E99
[6] Analysis of BRAF V600E Mutation in Japanese Patients with Langerhans Cell Histiocytosis
Hayase, Tomomi
Shioda, Yoko
Imamura, Toshihiko
Watanabe, Kenichiro
Ohki, Kentaro
Ohl, Yukiko
Kawaharal, Yuta
Morimotol, Akira
PEDIATRIC BLOOD & CANCER, 2018, 65 : S17 - S17
[7] Prevalence of the BRAF V600E mutation in Greek adults with Langerhans cell histiocytosis
Stathi, Dimitra
Yavropoulou, Maria P.
Allen, Carl E.
Abhyankar, Harshal
Scull, Brooks
Tsoli, Marina
Andreakos, Evangelos
Kaltsas, Gregory
Makras, Polyzois
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2022, 39 (06) : 540 - 548
[8] BRAF V600E Mutation: A Significant Biomarker for Prediction of Disease Relapse in Pediatric Langerhans Cell Histiocytosis
Ozer, Erdener
Sevinc, Akin
Ince, Dilek
Yuzuguldu, Resmiye
Olgun, Nur
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2019, 22 (05) : 449 - 455
[9] Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation
Haroche, Julien
Cohen-Aubart, Fleur
Emile, Jean-Francois
Arnaud, Laurent
Maksud, Philippe
Charlotte, Frederic
Cluzel, Philippe
Drier, Aurelie
Hervier, Baptiste
Benameur, Neila
Besnard, Sophie
Donadieu, Jean
Amoura, Zahir
BLOOD, 2013, 121 (09) : 1495 - 1500
[10] Analysis of BRAF V600E Mutation in Langerhans Cell Histiocytosis Using Pyrosequencing Technology
Halfacre, J.
Gale, J. M.
Vasef, M. A.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 660 - 660

← 1 2 3 4 5 →